They can also induce responses against normal tissue antigens, leading the immune system to attack normal tissues and cause
toxicity in a subset of patients.
In addition, HER2 is expressed in many normal tissues, giving systemic HER2 - targeted antibody therapy the potential to cause
toxicity in a subset of patients, including cardiac myopathy, congestive heart failure, and pulmonary toxicity [14], [15].
Not exact matches
If hypofractionated radiation with curative intent can reduce the treatment time for lung cancer
patients by half with no greater
toxicity, and with equivalent — if not better — tumor control and survival outcomes, this research could result
in a change
in the paradigm
of how a large
subset of locally advanced NSCLC
patients are treated.»